Nuveen Asset Management Raised Piedmont Office Realty Tr In (PDM) Stake By $19.42 Million; Shorts at Intermolecular (IMI) Lowered By 47.76%

November 14, 2017 - By Marguerite Chambers

Nuveen Asset Management Llc increased Piedmont Office Realty Tr In (PDM) stake by 392.4% reported in 2017Q2 SEC filing. Nuveen Asset Management Llc acquired 924,602 shares as Piedmont Office Realty Tr In (PDM)’s stock declined 3.76%. The Nuveen Asset Management Llc holds 1.16M shares with $24.46M value, up from 235,629 last quarter. Piedmont Office Realty Tr In now has $2.92 billion valuation. The stock decreased 0.49% or $0.1 on November 14, reaching $20.25. About 582,433 shares traded. Piedmont Office Realty Trust, Inc. (NYSE:PDM) has risen 9.82% since November 14, 2016 and is uptrending. It has underperformed by 6.88% the S&P500.

Intermolecular Incorporated (NASDAQ:IMI) had a decrease of 47.76% in short interest. IMI’s SI was 38,400 shares in November as released by FINRA. Its down 47.76% from 73,500 shares previously. With 25,500 avg volume, 2 days are for Intermolecular Incorporated (NASDAQ:IMI)’s short sellers to cover IMI’s short positions. The SI to Intermolecular Incorporated’s float is 0.28%. The stock decreased 4.35% or $0.05 on November 14, reaching $1.1. About 46,199 shares traded or 60.94% up from the average. Intermolecular Inc (NASDAQ:IMI) has declined 52.97% since November 14, 2016 and is downtrending. It has underperformed by 69.67% the S&P500.

Since May 24, 2017, it had 0 insider purchases, and 1 sale for $168,758 activity. 7,800 shares valued at $168,758 were sold by Moon Laura P on Wednesday, May 24.

Among 4 analysts covering Piedmont Office Realty Trust (NYSE:PDM), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Piedmont Office Realty Trust had 12 analyst reports since September 3, 2015 according to SRatingsIntel. The stock of Piedmont Office Realty Trust, Inc. (NYSE:PDM) earned “Hold” rating by Stifel Nicolaus on Friday, July 14. The rating was upgraded by Robert W. Baird to “Outperform” on Monday, August 28. Stifel Nicolaus maintained the stock with “Hold” rating in Monday, September 18 report. SunTrust maintained the stock with “Neutral” rating in Thursday, September 3 report. The stock of Piedmont Office Realty Trust, Inc. (NYSE:PDM) earned “Sell” rating by Stifel Nicolaus on Tuesday, May 10. The stock has “Neutral” rating by DA Davidson on Tuesday, May 3. The stock of Piedmont Office Realty Trust, Inc. (NYSE:PDM) earned “Hold” rating by Stifel Nicolaus on Thursday, November 2. Robert W. Baird downgraded it to “Neutral” rating and $21.0 target in Thursday, January 7 report. As per Monday, December 14, the company rating was downgraded by Stifel Nicolaus. The firm has “Hold” rating given on Monday, January 23 by Stifel Nicolaus.

Investors sentiment increased to 1.14 in Q2 2017. Its up 0.16, from 0.98 in 2017Q1. It increased, as 13 investors sold PDM shares while 66 reduced holdings. 27 funds opened positions while 63 raised stakes. 120.14 million shares or 1.23% less from 121.63 million shares in 2017Q1 were reported. Credit Agricole S A reported 97,000 shares. Natl Bank Of Montreal Can owns 192,191 shares for 0% of their portfolio. Martingale Asset Ltd Partnership owns 935,896 shares. Aperio Limited Liability Company holds 0% or 24,332 shares. Interest Grp Inc invested in 0% or 3,134 shares. California Employees Retirement System accumulated 526,361 shares. Sii Invests Inc Wi has invested 0.04% of its portfolio in Piedmont Office Realty Trust, Inc. (NYSE:PDM). Manufacturers Life Insurance Com The invested in 4,241 shares or 0% of the stock. Smith Asset LP invested in 1,901 shares. Hsbc Holdg Public Limited Liability Corporation invested in 0% or 17,220 shares. Renaissance Technologies Ltd Liability Co invested in 2.09M shares or 0.06% of the stock. Kempen Mgmt Nv reported 80,535 shares. Glenmede Trust Na, Pennsylvania-based fund reported 243 shares. Ameriprise Fin holds 0% or 204,548 shares in its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 11,401 shares.

Nuveen Asset Management Llc decreased Schlumberger Ltd (NYSE:SLB) stake by 409,374 shares to 39,123 valued at $2.58M in 2017Q2. It also reduced Smith A O (NYSE:AOS) stake by 70,454 shares and now owns 211,524 shares. Conocophillips (NYSE:COP) was reduced too.

Investors sentiment decreased to 0.45 in Q2 2017. Its down 1.55, from 2 in 2017Q1. It dived, as 3 investors sold Intermolecular Inc shares while 8 reduced holdings. 3 funds opened positions while 2 raised stakes. 18.81 million shares or 2.54% less from 19.29 million shares in 2017Q1 were reported. The Illinois-based Guggenheim Capital Ltd has invested 0% in Intermolecular Inc (NASDAQ:IMI). Morgan Stanley has 0% invested in Intermolecular Inc (NASDAQ:IMI). Bridgeway Cap Management Incorporated owns 247,600 shares. Raging Mgmt has 2.58% invested in Intermolecular Inc (NASDAQ:IMI) for 14.73M shares. Spark Limited Company holds 0.01% or 97,385 shares in its portfolio. Geode Capital Management Limited Liability Corporation holds 69,386 shares or 0% of its portfolio. 43,071 were accumulated by Rbf Ltd Liability. Thompson Siegel & Walmsley Limited Liability Corporation holds 0% or 2,400 shares. Blackrock stated it has 86,681 shares or 0% of all its holdings. Massachusetts-based Panagora Asset Mngmt Inc has invested 0% in Intermolecular Inc (NASDAQ:IMI). Aspiriant Ltd Liability Corp reported 0.01% of its portfolio in Intermolecular Inc (NASDAQ:IMI). Grt Capital Partners Ltd has invested 0.01% in Intermolecular Inc (NASDAQ:IMI). Moreover, Renaissance Tech has 0% invested in Intermolecular Inc (NASDAQ:IMI). Vanguard Gru has 512,816 shares for 0% of their portfolio. Tower Rech Capital Limited Liability Company (Trc) invested 0% of its portfolio in Intermolecular Inc (NASDAQ:IMI).

Intermolecular, Inc. provides thin film solutions. The company has market cap of $54.52 million. The Company’s high productivity combinatorial platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It currently has negative earnings. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marguerite Chambers




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: